通过此次收购，这家法国制药巨头将获得一款已在美国上市的乙肝疫苗，以及一款正处于早期人体试验 阶段的实验性带状疱疹疫苗。赛诺菲表示，此举将强化其在成人疫苗接种领域的市场布局。目前，赛诺 菲的疫苗产品组合已覆盖流感、呼吸道合胞病毒、脑膜炎、百日咳等多个适应症。 周三，德纳维制药(DVAX.US)盘前暴涨近40%，报15.56美元。消息面上，赛诺菲(SNY.US)同意以约22 亿美元的价格收购德纳维制药，旨在扩充其目前以流感疫苗业务为核心的疫苗产品线。根据赛诺菲周三 发布的声明，其将以每股15.50美元的现金价格，收购总部位于美国加利福尼亚州埃默里维尔市的德纳 维制药。这一报价较达德纳维制药周二的收盘价溢价39%。 ...

Core Viewpoint - The vaccination rate for adults aged 18-59 in China was only 0.52% in 2021, highlighting significant challenges in adult vaccination accessibility, affordability, and vaccine hesitancy, which increase health risks and burden on families and healthcare systems [1][2] Group 1: Current Situation and Challenges - The vaccination rates for chronic disease patients, such as those with COPD, are also concerning, indicating a need for improved adult immunization strategies [1] - Compared to Western countries, China's adult vaccination rates are significantly lower, with less than 1% of heart failure patients receiving flu vaccines, while rates in Western Europe and the US are around 60% [2] - Factors contributing to low vaccination rates include reliance on out-of-pocket payments, limited insurance coverage, and inadequate public health initiatives [2] Group 2: Expert Consensus and Recommendations - The "Expert Consensus on Health Promotion Strategies for Adult Vaccination" was released, advocating for a shift from child-focused vaccination to a life-cycle approach that includes adults [1][4] - Proposed strategies include establishing a three-in-one service network for adult vaccinations, integrating vaccination services into healthcare systems, and enhancing health education [4][5] - Pilot programs in regions like Chongqing and Shandong are being implemented to improve vaccination accessibility and integrate vaccination into routine healthcare [4][6]

Core Viewpoint - The release of the "Expert Consensus on Health Promotion Strategies for Adult Vaccination in China" emphasizes the necessity and health value of adult vaccination, particularly highlighting the importance of influenza vaccination in reducing disease incidence and healthcare burden [1][2]. Group 1: Importance of Adult Vaccination - The consensus identifies vaccination as the most economical and effective public health measure for preventing and controlling infectious diseases, which can reduce the incidence of various infectious diseases and some chronic diseases, as well as the risks of severe cases and mortality [1]. - Seasonal influenza vaccination can reduce hospitalization rates by 45% and mortality rates by 38% among elderly diabetic patients, and is associated with a decrease in cardiovascular mortality risk [2]. Group 2: Current Challenges - The public's awareness of the benefits of vaccination in preventing infections and reducing severe cases and mortality is low, and there exists a phenomenon of "vaccine hesitancy" among healthcare professionals [2]. - The current immunization program in China primarily focuses on children, with adult vaccination services largely dependent on medical institutions, resulting in a very low coverage rate for adult vaccinations [2]. Group 3: Recommendations for Improvement - The consensus suggests expanding adult immunization channels and improving the service system, including the establishment of independent adult vaccination clinics [3]. - It recommends integrating vaccination into comprehensive health management and gradually implementing preventive vaccination prescriptions by general practitioners, while also enhancing the responsibility of healthcare professionals in vaccine recommendations [3].

《中国成人疫苗接种健康促进策略专家共识》发布，流感防控成为重点方向 中新网北京11月20日电 近日，我国首个聚焦成人疫苗政策体系，多学科跨领域的专家共识——《中国 成人疫苗接种健康促进策略专家共识》(以下简称《共识》)发布。《共识》由清华大学健康中国研究 院、北京大学公共卫生学院、南方科技大学全科医学院、公共安全科学技术学会公共卫生安全与健康专 业委员会牵头，联合近50位专家学者共同制订。 《共识》聚焦成人疫苗接种的必要性与健康价值，针对我国成人免疫规划短板提出系统性解决方案，其 中流感疫苗接种作为降低人群发病风险、减轻医疗负担的关键举措，被多次提及。 流感等疫苗可预防的疾病给全龄人群带来了沉重的健康负担，在叠加感染的情况下，更带来严重的死亡 风险。《共识》建议，疫苗接种是预防和控制传染病最经济且有效的公共卫生措施，能够降低多种传染 病和部分慢性疾病的发生以及重症和死亡风险。 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 11月10日，在国家疾病预防控制局召开的"秋冬季急性呼吸道传染病防控 ...